Patterns of Neutropenia and Risk Factors for Febrile Neutropenia of Diffuse Large B-Cell Lymphoma Patients Treated with Rituximab-CHOP

Patterns of Neutropenia and Risk Factors for Febrile Neutropenia of Diffuse Large B-Cell Lymphoma Patients Treated with Rituximab-CHOP

Febrile neutropenia (FN) is the major toxicity of rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) regimen in the treatment of diffuse large B-cell lymphoma (DLBCL). The prediction of neutropenia and FN is mandatory to continue the planned R-CHOP therapy resulting i...

Full description

Bibliographic Details
Main Authors: Choi, Yong Won, Jeong, Seong Hyun, Ahn, Mi Sun, Lee, Hyun Woo, Kang, Seok Yun, Choi, Jin-Hyuk, Jin, U Ram, Park, Joon Seong
Format: Online
Language:English
Published: The Korean Academy of Medical Sciences 2014
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4234916/

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4234916/

Similar Items